Whole-Genome Diagnostics Evolve with RNA and Pangenome Integration
Oct 13, 2026
In an effort to find elusive rare diseases, Ambry has developed GenomeNext, a test that combines more thorough sequencing with diverse genomic references and ongoing…
Read MoreCancer Genetic Testing Uptake Improves with Digital Outreach and Health Coaching
Oct 14, 2026Advanced Omics Reveal ‘Poor Outcome’ Marker for Neuroblastoma
Oct 14, 2026Mechanical Pressure Triggers Cancer Cell Death, Revealing Potential New Defense Against Metastasis
Oct 14, 2026Magnetic Millirobots Could Deliver Cancer Drugs Directly to Hard-to-Reach Tumors
Oct 14, 2026Single-Cell Profiling Exposes Hidden Diversity Within Pancreatic Tumors
Oct 14, 2026Trapping ecDNA in Micronuclei Improves Cancer Patient Survival
Oct 14, 2026Candida auris Copies Whole Genome to Evade Antifungal Treatment
Oct 15, 2026
Worlds Apart: Genomics Experts Still Split on Newborn Sequencing Guidelines
Oct 14, 2026
Metabolomic Aging Clock Predicts Chronic Disease, Mortality Risk
Oct 14, 2026
CRISPR-Based Test Improves Detection of HIV and Other RNA Viruses
Oct 14, 2026
Childhood Cancer Linked with Abnormal Antibodies
Oct 14, 2026
Rare Immune Disorders Caused by Bursting White Blood Cells
Oct 13, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Reporter’s Notebook: Cell and Gene Therapy’s Success Lies Beyond the Bespoke (Part 1)
Oct 10, 2026Conversations with the CEOs of Skylark Bio, Prime Medicine, and Cellares and Nanoscope Therapeutics executives highlighted differentiated technologies and scalable platforms serving broader patient populations.
Major Trial Finds NAD-Boosting Supplement Does Not Slow Parkinson’s Disease
Oct 9, 2026A large clinical trial has challenged the therapeutic promise of NAD-boosting supplements in Parkinson’s disease. Despite encouraging earlier findings, nicotinamide riboside failed to improve clinical…
The Legality of Genetic Privacy in Newborn Screening
Oct 8, 2026Deciding whether to get genetic screening, whether the patient is an infant or adult, can be a challenging choice. At ICoNS, Natalie Ram, JD, discussed…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
